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1. Introduction
The gut mucosal barrier has a complicated relationship with 
both luminal contents and the underlying immune cells of 
the lamina propria and Peyer’s patches. The fundamental 
function of this mucosal barrier is to protect host tissue 
from damage, mediated by luminal pathogens and toxic 
products obtained from either pathogenic bacteria or 
food, while at the same time allowing uptake of nutrients. 
The mucosal barrier thus determines gut immune cell 
fate as either immune activation in response to pathogens 
or inducing immune hypo-responsiveness, thereby 
tolerating non-harmful beneficial products, such as food 
and commensal microbes. Integral to this mucosal barrier 
function is the interrelationship with commensal non-
pathogenic bacteria. These resident commensal bacteria or 
exogenous bacteria in the case of ingested probiotic bacteria 
are beneficial to the host by maintaining barrier integrity, 
competing with pathogens for nutrients and binding sites 
on epithelial cells and modulating immune function by 
either stimulating or tolerising immune responses (Walker, 
2008). The recognition by and interaction of harmful or 
non-harmful beneficial bacteria with epithelial cells is thus 
of paramount importance to immune fate, i.e. tolerance 
or activation.
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Abstract
The inducible antimicrobial peptide human β-defensin-2 (hBD-2) stimulated by pro-inflammatory cytokines and 
bacterial products is essential to antipathogen responses of gut epithelial cells. Commensal and probiotic bacteria 
can augment such mucosal defences. Probiotic use in the treatment of inflammatory bowel disease, however, 
may have adverse effects, boosting inflammatory responses. The aim of this investigation was to determine the 
effect of selected probiotic strains on hBD-2 production by epithelial cells induced by pathologically relevant 
pro-inflammatory cytokines and the role of cytokine modulators in controlling hBD-2. Caco-2 colonic intestinal 
epithelial cells were pre-incubated with heat-killed probiotics, i.e. Lactobacillus casei strain Shirota (LcS) or 
Lactobacillus fermentum strain MS15 (LF), followed by stimulation of hBD-2 by interleukin (IL)-1β and tumour 
necrosis factor alpha (TNF-α) in the absence or presence of exogenous IL-10 or anti-IL-10 neutralising antibody. 
Cytokines and hBD-2 mRNA and protein were analysed by real-time quantitative polymerase chain reaction and 
enzyme-linked immunosorbent assay. LcS augmented IL-1β-induced hBD-2, whereas LF enhanced TNF-α- and 
suppressed IL-1β-induced hBD-2. LF enhanced TNF-α-induced TNF-α and suppressed IL-10, whereas augmented 
IL-1β-induced IL-10. LcS upregulated IL-1β-induced TNF-α mRNA and suppressed IL-10. Endogenous IL-10 
differentially regulated hBD-2; neutralisation of IL-10 augmented TNF-α- and suppressed IL-1β-induced hBD-2. 
Exogenous IL-10, however, suppressed both TNF-α- and IL-1β-induced hBD-2; LcS partially rescued suppression 
in TNF-α- and IL-1β-stimulation, whereas LF further suppressed IL-1β-induced hBD-2. It can be concluded that 
probiotic strains differentially regulate hBD-2 mRNA expression and protein secretion, modulation being dictated 
by inflammatory stimulus and resulting cytokine environment.
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A protective mechanism elicited by epithelial cells in 
response to a broad range of Gram-positive and Gram-
negative pathogens is the production and secretion of 
antimicrobial peptides (AMPs), such as defensins and 
cathelicidins (Kluver et al., 2006). Colonic epithelial cells 
have been described as potent producers of the inducible 
antimicrobial human β-defensin-2 (hBD-2). Defensins 
are small cationic peptides produced by epithelial cells, 
Paneth cells, neutrophils and macrophages contributing 
to broad spectrum innate immunity. hBD-2 is an inducible 
AMP with a molecular mass of 4-6 kD acting as an 
endogenous antibiotic in the defence against potential 
pathogenic microbes of the gut (for review, see Ganz, 
2003). This AMP can be induced by endogenous stimuli, 
such as inflammatory cytokines (e.g. interleukin (IL)-1β, 
tumour necrosis factor alpha (TNF-α) and IL-22) as well 
as exogenous microbial products and their microbial 
associated molecular patterns (MAMPs) (Vora et al., 2004). 
Due to their conserved nature, it is probable that MAMPs 
shared between pathogenic and probiotic bacteria display 
both beneficial and detrimental effects to the host, playing 
a pivotal role in homeostatic regulation in the gut mucosa 
as well as a pro-inflammatory pathological role.
Upon mucosal dysfunction and barrier breakdown, such as 
observed in inflammatory bowel diseases (IBDs), Crohn’s 
disease (CD) and ulcerative colitis (UC), hBD-2 has been 
reported to be suppressed (Wehkamp et al., 2005). Indeed, 
it has been observed that there is a differential expression 
of inducible and constitutive β-defensins in CD and UC 
(Wehkamp et al., 2003). The overgrowth of hBD-2-sensitive 
pathogenic bacteria would represent a realistic mechanism 
of potentiation of such an inflammatory pathology of the 
gastro-intestinal tract (GIT). The immunopathology of 
these IBDs is driven by dysregulated T cell and macrophage 
function and the production of tissue-destructive 
proinflammatory cytokines (Foey, 2012). CD has been 
described to be driven by pathogenic mechanisms resulting 
from dysregulation in innate pattern recognition receptors, 
sensing and through the predominant differentiation 
and activation of T-helper Th1 and Th17 subsets. This 
combination was found to result in dysregulated expression 
and functionality of IL-12, IL-23, IL-6, IL-1β, interferon 
gamma, IL-17 and TNF-α, which initiate and perpetuate 
inflammation. The suppression of hBD-2 observed in CD 
would seem to be integrally linked with this inflammatory 
cytokine profile, as hBD-2 enhances T cell IL-10 production 
whilst suppressing IL-17 (Kanda et al., 2011). The lack of 
hBD-2 would thus have the reverse effect, suppressing the 
anti-inflammatory cytokine IL-10 and augmenting IL-17, 
potentiating inflammatory pathological mechanisms in IBD.
In addition to their antimicrobial role, defensins have been 
shown to display other functions that mediate immune 
responses and inflammation. For example, defensins have 
been described to augment IL-8 production (Kluver et 
al., 2006; Van Wetering et al., 1997a,b) and both α- and 
β-defensins to be chemotactic for T cells, DCs, macrophages 
and monocytes (Chertov et al., 1996; Garcia et al., 2001; 
Territo et al., 1989; Yang et al., 2000). Defensins have been 
demonstrated to augment TNF-α and IL-1β production at 
the site of microbial infection, thus amplifying inflammatory 
mechanisms (Chaly et al., 2000), whereas hBD-2, as 
indicated above, also possesses an anti-inflammatory/
regulatory role by enhancing IL-10 and suppressing the 
pro-inflammatory cytokine IL-17 (Kanda et al., 2011). 
It would appear that hBD-2 induction can exhibit either 
pro- or anti-inflammatory effects, overall response being 
determined by environmental context.
Probiotic bacteria have been suggested to be beneficial 
to the GIT by reinforcing mucosal barrier defences via 
the induction of antimicrobial peptides, such as hBD-2. 
Indeed, earlier studies have shown that the probiotic strain 
Escherichia coli Nissle 1917 induced hBD-2 expression 
and production in Caco-2 epithelial cells and that the 
molecule predominating this induction is the Toll-like 
receptor 5 pathogen-associated molecular pattern (PAMP) 
flagellin (Schlee et al., 2007; Wehkamp et al., 2004). In 
addition, hBD-2 was found to be induced in Caco-2 cells 
by a range of specific lactic acid bacteria (LAB) strains 
and combinations, such as VSL#3 formulation; hBD-2 
mRNA expression was induced by LAB, peaking at 6 h and 
persisting to 24 h, whereas secretion of hBD-2 peptide was 
very low in comparison to mRNA expression (Schlee et al., 
2008). Our previous investigations have demonstrated that 
probiotic bacteria exert differential effects on inflammation 
(immunoactivatory or immunoregulatory) and that 
the overall modulation of the resulting response was 
dependent on the inflammatory context of immune cell 
and probiotic strain being used (Habil et al., 2011, 2012). 
When administered prophylactically, certain probiotic 
bacteria have been documented to afford health benefits 
to healthy subjects through the modulation of immune 
mechanisms via immunostimulation or -regulation. Indeed, 
this health benefit has been demonstrated in reduced 
incidence of allergic pathologies and cancer (Ishikawa 
et al., 2005; Kalliomaki et al., 2003; Rafter et al., 2007; 
reviewed in Hardy et al., 2013). The specific health benefits 
of probiotics administered during chronic inflammatory 
pathology, however, are less well established. The aim of this 
study was to investigate the immunomodulatory effects of 
selected probiotic bacterial strains on the induction of hBD-
2 expression and secretion by a cell line model of human 
intestinal epithelial cells in the presence of inflammatory 
cytokines that predominate and drive IBD pathogenesis.
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2. Materials and methods
Bacterial culture and preparation of heat-killed extract
Lactobacillus fermentum strain MS15 (LF) was isolated 
from the crop of a chicken (Savvidou, 2009) and kindly 
provided by Dr. Jane Beal from internal microbiology 
stocks at the University of Plymouth (UK). Lactobacillus 
casei strain Shirota (LcS) was obtained from a commercial 
probiotic product (Yakult Honza Ltd., Tokio, Japan). All 
probiotic bacterial species were cultured in De Man Rogosa 
Sharp (MRS) broth at 37 °C for 18 h until the beginning of 
the stationary phase. Heat-killed (HK) bacterial samples 
was prepared according to the method described by Young 
et al. (2004). In brief, bacterial cells were centrifuged and 
washed twice in phosphate buffered saline; viable counts 
were adjusted to a density of 1×109 cfu/ml. Probiotic 
bacteria were heat-killed for 2 h at 90 °C. To confirm death 
of bacteria, all Lactobacillus spp. samples were plated on 
MRS agar and incubated for a minimum of 18 h. All HK 
bacterial extracts were Gram stained to check bacterial 
integrity after heating.
Cell culture
Caco-2 (human colon adenocarcinoma) epithelial 
cell line was kindly provided by Dr. Maria O’Connell 
(HNR, Cambridge, UK). Caco-2 cells were maintained 
in D10 medium, Dulbecocos’ Modified Eagles’ Medium 
(DMEM) supplemented with 10% (v/v) foetal calf serum, 
2 mM L-glutamine, 100 U/ml penicillin, and 100 µg/ml 
streptomycin (Lonza, Wokingham, UK). Cells were plated 
at a density of 5×105 cells/ml and cultured in D10 medium 
in a humidified atmosphere at 37 °C and 5% CO2 for 21 
days to allow for full cell differentiation.
Modulatory effect of heat-killed probiotic bacteria
Differentiated Caco-2 cells were pre-incubated in D10 
medium for 18 h without or with HK probiotic bacteria at 
a predefined optimal density equivalent of 1×108 cfu/ml. 
As HK probiotic bacteria gave similar hBD-2 mRNA 
induction time course profiles as live bacteria (shown in 
Results section), the former were adopted for subsequent 
experimentation to negate any effects of lactic acid on cell 
viability, hence indirectly modulating hBD-2 responses. 
Pre-incubation was followed by stimulation with pro-
inflammatory cytokines prevalent in IBD, i.e. 10 ng/ml 
TNF-α or 10 ng/ml IL-1β, over a pre-determined time 
point of 18 h optimal for pro-inflammatory cytokine 
stimulation and HK bacteria to induce hBD-2 mRNA 
expression and protein secretion from Caco-2 cells (shown 
in Results section). TNF-α-induction of TNF-α protein is 
problematic, when measuring secretion of TNF-α protein. 
To circumvent it, Caco-2 cells were stimulated using a 
pulse-chase protocol. Cells were stimulated by 10 ng/ml 
exogenously added TNF-α for 6 h, whereafter TNF-α was 
washed off the cells, replaced by fresh D10 medium and 
incubated (chased) up to 18 h. Cell viability of differentiated 
Caco-2 cells was routinely monitored by the MTT assay 
and found to be unaffected by the reagent concentrations 
and the incubation times used.
Effect of endogenous IL-10 on hBD-2 induction
To find out whether the induction of hBD-2 and its 
modulation by probiotic bacteria was associated with 
endogenous IL-10 activity, a neutralising antibody was 
employed. Caco-2 cells were pre-incubated for 18 h without 
or with HK probiotic bacteria followed by stimulation with 
either TNF-α or IL-1β in the absence or presence of the 
neutralising antibody anti-human IL-10 (clone JES3-9D7; 
Biolegend, San Diego, CA, USA) at a concentration of 10 
µg/ml. This concentration has previously been shown to 
neutralise 10 ng/ml IL-10 (Parry et al., 1997). Epithelial 
cells were incubated for another 18 h, whereafter they 
were washed and collected for mRNA extraction 
and quantification of hBD-2 gene expression; culture 
supernatant was collected to detect secreted hBD-2 protein 
by enzyme-linked immunosorbent assay (ELISA).
Real-time qPCR analysis of gene expression
Expression of hBD-2, TNF-α, IL-10 and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) mRNA was assessed 
by real-time quantitative polymerase chain reaction 
(RT-qPCR). Following each treatment, the cells were 
washed with ice-cold PBS and total RNA was extracted 
using GenElute RNA isolation kit (Sigma-Aldrich, Poole, 
UK) according to the manufacturer’s instruction. The 
total RNA concentration was determined using NanoVue 
spectrophotometer (GE Healthcare, Freiberg, Germany). 
RNA purity was assessed by examining the absorbance 
ratio at 260 and 280 nm, while integrity was verified 
by electrophoresis on 1% denaturing agarose gel. One 
microgram of total RNA was reverse transcribed using 
MMLV Reverse Transcriptase reaction kit (Sigma-Aldrich) 
as suggested by the supplier.
Sequence specific primers for hBD-2, TNF-α, IL-10 and 
GAPDH (Table 1) were designed using Primer Express 
Software (Applied Biosystems, Paisley, UK) and synthesised 
by Eurofins MWG Operon (Ebersberg, Germany). 
RT- qPCR was performed using StepOnePlus thermal 
cycler and Power SYBR Green kit (Applied Biosystems, 
Foster City, CA, USA) using 10 pmol of the forward and 
reverse primers for each target. Target amplification was 
carried out under the following conditions: preheating at 
95 °C for 10 min, followed by 40 cycles at 95 °C for 30 s, 
60 °C for 1 min and 72 °C for 1 min. RT-qPCR data were 
analysed following the 2-ΔΔCt method as described by Livak 
and Schmittgen (2001) using GAPDH as an endogenous 
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control and resting cells as a reference sample. Thus, the 
relative quantity of the target transcript is described as fold 
increase (RQ, relative quantitation) relative to the reference 
sample and GAPDH.
Quantification of hBD-2 and cytokine secretion
Secretion of hBD-2 and the cytokines IL-10 and TNF-α into 
cell culture supernatants by treated Caco-2 epithelial cells 
was quantified by sandwich enzyme-linked immunosorbent 
assay (ELISA) using commercially available paired capture 
and detection antibodies for TNF-α and IL-10 (BD-
Pharmingen, Oxford, UK), and hBD-2 (PeproTech EC 
Ltd., London, UK). Protocols according to manufacturer’s 
instructions were followed and compared to standard 
curves of recombinant human cytokines using recognised 
international cytokine standards available from NIBSC 
(Potter’s Bar, UK) and recombinant hBD-2 (PeproTech 
EC Ltd.) over the range of 7 to 5,000 pg/ml. Colorimetric 
development was determined by an OPTIMax tuneable 
microplate reader at 450 nm and analysed by Softmax Pro 
software version 2.4.1 (Molecular Devices Corp., Sunnyvale, 
CA, USA).
Statistical analysis
Statistical analysis was performed using one-way analysis 
of variance (ANOVA). Statgraphics Software version 5.1 
(Informer Technologies, Inc.) was used to analyse the data. 
All data are expressed as the mean ± standard error of 
triplicate values for a representative experiment of at least 
three independent experiments. Statistical significance of 
treatment compared to stimulation control is indicated by 
a P-value <0.05.
3. Results
Induction of epithelial cell hBD-2 by probiotic bacteria 
and pro-inflammatory cytokines
The ability of probiotic bacteria and pro-inflammatory 
cytokines associated with inflammatory pathology (TNF-α 
and IL-1β) to modulate epithelial cell induction of hBD-2 
expression was investigated. Live and HK probiotic bacteria 
were incubated over a time period of 24 h with Caco-2 
epithelial cells. At 1x103 and 1x106 cfu/ml, no significant 
difference was observed between induction of hBD-2 
mRNA expression by live and HK bacteria. However, a 
significant difference was observed at 1×109 cfu/ml. From 
12 to 24 h, relative hBD-2 mRNA levels were increased 
by 1000% and 1,300% for live LcS and LF, respectively 
(Figure 1A), whereas HK LcS and LF resulted in 23,800% 
and 23,100% augmentation, respectively, over the same 
period (Figure 1B). hBD-2 was truly inducible; no detectable 
mRNA levels were observed in unstimulated epithelial cells 
over the same time period and no protein secretion was 
detected over the lower levels of sensitivity of the sandwich 
ELISA (7 pg/ml) (data not shown).
The pro-inflammatory cytokines TNF-α and IL-1β 
predominating the pathology of chronic IBD were found 
to induce both expression of hBD-2 mRNA (Figure 1C) 
and protein secretion (Figure 1D) over a time period of 
24 h. No hBD-2 mRNA expression or secreted protein 
was detected in unstimulated cells. The kinetics of hBD-2 
protein secretion were comparable for both TNF-α and 
IL-1β stimulation; protein secretion continued beyond 18 
h, at which time point hBD-2 secretion was 81±1 and 91±4 
pg/ml, respectively. Expression of hBD-2 mRNA peaked at 
9 h for IL-1β and 18 h for TNF-α. Both TNFα- and IL-1β-
induced hBD-2 mRNA persisted beyond 20 h incubation 
(Figure 1C).
Modulation of hBD-2 depending on inflammatory 
environment
The pro-inflammaotry cytokines TNF-α and IL-1β clearly 
induced hBD-2 in Caco-2 cells (Figure 2). Probiotic 
modulation of the epithelial cell defence is less clear with 
respect to inflammatory pathology of the gastrointestinal 
tract. Depending on disease classification, environmental 
factors and genetics either IL-1β or TNF-α can predominate 
in driving destructive inflammatory pathological 
mechanisms observed in IBD. It was hypothesised that 
TNF-α- and IL-1β-stimulated epithelial cells would exhibit 
differential probiotic modulation of hBD-2 induction. 
Table 1. Sequence of real-time PCR primers and estimated product size.
Target name Forward primer 5’- Size (bp) Reverse primer 3’- Size (bp) Product size (bp) 
GAPDH CTGCTCCTCCTGTTCGACAGT 21 CCGTTGACTCCGACCTTCAC 23 100 
hBD-2 CACCTGTGGTCTCCCTGGAA 20 CTCTGATGAGGGAGCCCTTTC 17 100 
TNF-α ACATCCAACCTTCCCAAACG 20 GCCCCCAATTCTCTTTTTGAG 22 151 
IL-10 AGGAGGTGATGCCCCAAGCTGA 22 TCGATGACAGCGCCGTAGCCT 21 110 
Abbreviations used: GAPDH = glyceraldehyde-3-phosphate dehydrogenase;  hBD-2= human β-defensin-2; TNF- α = tumour necrosis factor alpha; IL-10 
= interleukin-10.
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Figure 1. Induction of human β-defensin -2 (hBD-2) in intestinal epithelial cells by live and heat-killed probiotic bacteria, and pro-
inflammatory cytokines. Caco-2 cells were incubated with (A) live and (B) heat-killed Lactobacillus casei strain Shirota (LcS) or 
Lactobacillus fermentum (LF) at 1×103, 1×106 and 1×109 cfu/ml for an incubation time course up to 24 h. The effects of culture 
with the pro-inflammatory cytokines, TNFα (10 ng/ml) and IL-1β (10 ng/ml), on the induction of (C) hBD-2 mRNA expression and (D) 
protein secretion over 24 h is also shown. Induction of hBD-2 mRNA expression is presented as relative expression (RQ) compared 
to GAPDH housekeeping gene expression, and protein secretion as the mean hBD-2 protein (pg/ml) ± standard deviation. Data 
shown are of triplicate samples for a representative experiment of n=3 independent replicate experiments.
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Figure 2. Heat-killed probiotic bacteria differentially modulate epithelial cell hBD-2 induced by the pro-inflammatory cytokines, 
IL-1β and TNFα. Caco-2 cells were pre-treated without or with heat-killed Lactobacillus casei strain Shirota (LcS) or Lactobacillus 
fermentum (LF) for 18 h followed by stimulation with 10 ng/ml TNFα (A and B) or 10 ng/ml IL-1β (C and D) for a further 18 h. 
Induction of hBD-2 mRNA expression (A and C) is presented as relative expression (RQ) compared to GAPDH housekeeping gene 
expression, and protein secretion (B and D) as the mean hBD-2 protein (pg/ml) ± standard deviation. Data shown are of triplicate 
samples for a representative experiment of n=3 independent replicate experiments. Significant effects of the probiotic strains 
are compared to the cytokine-stimulated control and are indicated as * P<0.05, ** P<0.01, *** P<0.001 and ns (not significant).
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Indeed, the probiotics studied modulated hBD-2 in a strain-
dependent manner. TNF-α induction of hBD-2 mRNA was 
suppressed by LcS (75%; P<0.001) and augmented by LF 
(65%: P<0.001) (Figure 2A). TNF-α-induced hBD-2 protein 
secretion was augmented by LF (28%; P=0.045), whereas 
LcS did not modulate hBD-2 protein secretion (P=0.126) 
(Figure 2B). Compared to TNF-α, IL-1β induction of hBD-2 
mRNA showed a different pattern. hBD-2 mRNA (Figure 
2C) and protein secretion (Figure 2D) were suppressed 
by pretreatment with LF and augmented by LcS. LF 
suppressed induction of hBD-2 mRNA by 39% (P<0.001) 
and protein secretion by 12% (P=0.018; LcS augmented 
mRNA expression by 47% (P<0.001) and protein secretion 
by 15% (P=0.005).
Modulation of TNF-α- and IL-1β-induced cytokines by 
heat-killed probiotic bacteria
In the homeostatic regulatory mucosal environment, 
mucosal epithelial cells and tissue as a whole exhibit a 
tolerogenic or regulatory/anti-inflammatory environment 
characterised by anti-inflammatory cytokines, such as IL-10. 
On the other hand, expression of TNF-α is prevalent in 
inflammatory mucosal environments. It is likely that both IL-
10 and TNF-α exert modulatory effects on the production of 
hBD-2 and that they are differentially modulated in intestinal 
epithelial cells by HK probiotic bacteria. The probiotic 
bacteria LcS and LF differentially modulated epithelial cell 
TNF-α and IL-10 in a manner dependent on inflammatory 
stimuli, TNF-α or IL-1β, and  probiotic bacterial strain. LcS 
suppressed TNF-α-induced TNF-α mRNA (48%; P=0.125), 
whereas LF augmented it (270%; P<0.001); protein levels, 
however, were unchanged in the presence of LcS (P=0.583) 
but increased by LF (37%; P=0.031) (Figures 3A and B). 
TNF-α-induced IL-10 mRNA was augmented by 10% by LcS 
(P=0.629) and suppressed by LF by 61.5% (P=0.021) (Figure 
3C). This trend was also seen for IL-10 protein secretion, 
which was not modulated by LcS (P=0.707) but suppressed 
by LF (73%; P=0.003) (Figure 3D).
In contrast, probiotic modulation of IL-1β-induced 
Caco-2 cell cytokines exhibited a different pattern compared 
to TNF-α-induced inflammatory cytokines. IL-1β induced 
TNF-α mRNA; LcS and LF enhanced this induction by 
4,300% (P<0.001) and 200% (P=0.125), respectively 
(Figure 4A). This result was not reflected in TNF-α protein 
secretion, which was not modulated by LcS and LF (Figure 
4B). IL-1β induction of IL-10 expression displayed a similar 
trend regarding mRNA and protein, but also showed a 
probiotic strain-dependent modulation. LcS suppressed 
IL-10 (83% for mRNA, P<0.001; 65% for protein secretion, 
P<0.001) and LF augmented this anti-inflammatory/
regulatory cytokine (316% for mRNA, P<0.001; 75% for 
protein secretion, P<0.001) (Figures 4C and D).
Endogenous IL-10 activity differentially regulates 
cytokine-induced hBD-2
Due to the rather modest levels of protein secreted 
in the supernatant, and the need to make a direct link 
between probiotic modulation of the cytokines and the 
subsequent induction of hBD-2, the role of endogenous cell-
associated anti-inflammatory IL-10 was investigated using 
a neutralising antibody. Data clearly show that endogenous 
IL-10 differentially modulates TNF-α- and IL-1β-induced 
hBD-2 in intestinal epithelial cells. The profile obtained for 
hBD-2 protein produced (Figure 5B) and secreted into the 
supernatant follows that of hBD-2 mRNA expression (Figure 
5A). In the absence of inflammatory stimuli, epithelial 
cells do not express or secrete hBD-2; neutralisation 
of endogenous IL-10 activity, however, resulted in 
augmentation of both hBD-2 mRNA (2,500%; P<0.001) 
and protein (1,600%; P<0.001). TNF-α-induced hBD-2 
mRNA and protein were augmented upon neutralisation of 
endogenous IL-10 by 250% (P<0.001) and 180% (P<0.001), 
respectively. In contrast to these observations, endogenous 
IL-10 exhibited a differential effect on IL-1β-stimulated 
hBD-2. Neutralisation of endogenous IL-10 suppressed 
mRNA expression by 83% (P<0.001) and hBD-2 protein 
secretion by 50% (P<0.001).
Exogenous IL-10 differentially regulates cytokine-induced 
hBD-2
As suggested by the neutralisation of endogenous IL-10 
activity, IL-10 could both negatively and positively regulate 
hBD-2 under certain inflammatory environments. This was 
further investigated by the addition of exogenous IL-10 
in the presence of the pro-inflammatory stimulators of 
epithelial cell hBD-2. The addition of exogenous IL-10 
to TNF-α-stimulated epithelial cells resulted in a clear 
suppression of hBD-2 mRNA by 96% and protein by 83%. 
Exogenous IL-10 also suppressed IL-1β-stimulated hBD-
2, but to a lesser extent; mRNA was suppressed by 57% 
and protein by 27% (Figures 6). In addition, the effect of 
the probiotic strains LcS and LF on this modulation of 
hBD-2 by exogenous IL-10 was also investigated. The 
modulation observed was dependent on the inflammatory 
cytokine inducing hBD-2 and the probiotic strain. When 
stimulated by TNFα, both probiotic strains partially rescued 
IL-10-induced suppression of hBD-2 mRNA and secreted 
protein. The suppression of hBD-2 mRNA to 4% of the 
TNF-α stimulus control was increased to 13% (P=0.121) 
and 48% (P<0.001) following the addition of LcS and LF, 
respectively, whereas hBD-2 protein suppressed to 17% of 
the TNF-α stimulus control was increased to 32% (P=0.036) 
and 49% (P<0.001) by the probiotic strains (Figures 6A 
and B). Regarding IL-1β-induced hBD-2, LcS completely 
rescued mRNA expression and even augmented expression 
by 41% of the IL-1β stimulus control (P<0.001); LF rescued 
IL-10 suppression from 43% to 88% (P<0.001) (Figure 6A). 
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experiments. Significant effects of probiotic strains are compared to the TNFα-stimulated control and are indicated as * P<0.05, 
*** P<0.001 and ns (not significant).
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This profile of probiotic modulation of IL-10 suppression 
of IL-1β-induced hBD-2 mRNA was not repeated when 
observing the effects on secreted protein induction. LcS 
partially rescued the IL-10-mediated suppression from 73% 
to 84% of the IL-1β stimulus control (P=0.065), whereas LF 
showed a further suppression from 73% to 36% (P<0.001) 
(Figure 6B).
4. Discussion 
The HK probiotic strains LcS and LF were shown to exhibit 
a differential modulatory activity on hBD-2 induced during 
an inflammatory signal, such as provided by TNF-α or 
IL-1β. These cytokines are representative of inflammatory 
pathology and associated with IBD pathogenesis (Strober et 
al., 2010). However, the design of the present experimental 
procedure was representative of acute inflammatory 
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episodes and the modulation of these episodes using a 
regimen of probiotic transient pretreatment. This study 
should be extrapolated to consider chronic inflammation, 
in which TNF-α or IL-1β are present for much longer time 
periods. Chronic stimulation by pro-inflammatory cytokines 
has been indicated to induce immune hyporesponsiveness 
(Cope, 1998; Cope et al., 1994, 1997); whether such an 
effect is observed with epithelial cells awaits investigation. 
In addition, the modulatory effects observed with the 
HK probiotic bacteria might be completely different on 
chronically stimulated epithelial cells. These studies are 
vital to our understanding of the efficacy of probiotic use 
for early or late-stage IBD.
Probiotics are generally viable beneficial microbes. The 
use of HK bacteria in this study was not ideal but needed 
for the interpretation of responses observed, in the context 
of studying the direct modulatory activity of probiotic 
bacteria on induction of hBD-2 in intestinal epithelial 
cells. Probiotics, such as LABs, produce acid endproducts, 
which have grave effects on epithelial cell functionality and 
viability. In the absence of a complete gut microbiome, 
digesta, mucus glycocalyx, and family of interacting 
immune cells and lamina propria cells, epithelial cells are 
extremely sensitive to these acid endproducts. Heat-killing 
probiotic bacteria was adopted to minimise acid effects. 
This represented a compromise at a defined metabolic 
snap-shot of bacterial growth. More eloquent approaches 
considered included acid neutralisation, reduction of 
metabolic activity by low glucose concentrations and the 
use of antibiotics; alternative methods that are not without 
problems when considering effects of metabolic activity.
The HK probiotic strains LcS and LF, and the pro-
inflammatory cytokines TNFα and IL-1β induced hBD-2 
mRNA expression. Optimal expression occurred from 12 
h onwards and persisted to 24 h for each stimulus, secreted 
protein levels being optimal at 18 h of stimulation. This 
would suggest that (1) hBD-2 mRNA was very stable, as it 
persisted up to and beyond 18 h, and p38 mitogen-activated 
protein kinase (MAPK) might play a predominant role 
in hBD-2 expression, as this signal component is well 
established to result in stabilisation of mRNA transcripts 
(Tudor et al., 2009) through the binding of factors such 
as tristetraprolin (TTP) to the 3’UTR of TNF-α; and (2) 
levels of hBD-2 protein being secreted did not conform 
to such high induction levels of mRNA. This is suggestive 
of significant posttranscriptional and posttranslational 
regulation, where relatively low levels of protein secreted 
may be explained by intracellular protein or endogenous 
cell membrane-associated hBD-2 activity being induced by 
cytokines (Hugo et al., 2010). This observation appears to 
conform to the data of Schlee et al. (2008). These authors 
observed very low hBD-2 secretion upon heat-inactivated 
probiotic stimulation; LF strain PZ1162 induced secretion 
up to 0.4 pg hBD-2 per 106 Caco-2 cells. In contrast to the 
present study, Schlee et al. (2008) described that hBD-2 
mRNA was rapidly induced, peaking at 6 h. This might 
be the consequence of using undifferentiated and 21-day-
differentiated Caco-2 cells. The present study demonstrated 
early mRNA and protein secretion when Caco-2 cells 
were stimulated by TNF-α and IL-1β. With respect to 
modulation of pro-inflammatory cytokine-induced 
hBD-2, LF suppressed IL-1β-induced hBD-2 mRNA and 
secreted protein, whereas LcS augmented hBD-2. This was 
in contrast with TNF-α-induced hBD-2; LcS suppressed 
TNF-α-induced hBD-2 mRNA expression, while LF 
augmented TNFα-induced mRNA and protein secretion. 
This suggests that TNFα-induced hBD-2 protein is strain-
dependent. There is need to fully investigate probiotic 
modulation of posttranscriptional and posttranslational 
mechanisms involved in hBD-2 production.
In these longer-term cultures (pretreatment with HK 
bacteria for 18 h followed by a stimulation period of 18 h), it 
is not clear whether HK probiotic bacteria modulate TNF-α- 
and IL-1β-induced production of hBD-2 or, conversely, 
pro-inflammatory cytokines modulate probiotic-driven 
hBD-2 response. This study attempted to investigate how 
probiotics modulate hBD-2 induced in the presence of 
an inflammatory stimulus predominating in gut mucosal 
pathologies, such as CD. The longer time duration of 
probiotic pretreatment adopted was representative of a time 
where direct probiotic effects on hBD-2 are on the decrease 
(Schlee et al., 2008) and mimicked the real-life delivery of 
probiotics over a protracted time period. Whether this 
approach is relevant to short-term early-stage or chronic 
IBD and probiotic treatment is beneficial or detrimental 
awaits clarification. In addition to the direct induction of 
this antimicrobial peptide, hBD-2 may also exert both a 
positive feed-back auto-induction loop and directly regulate 
inflammatory cytokines. Thus, modulation of hBD-2 will 
exhibit immunomodulatory properites (Biragyn et al., 2002; 
Chaly et al., 2000; Kanda et al., 2011; Presicce et al., 2009; 
and reviewed in Kluver et al., 2006).
Cytokines are pivotal to the immune-responsiveness of gut 
mucosal tissue. Here, the anti-inflammatory/regulatory 
cytokine, IL-10 is integral to mucosal tolerance and tissue 
homeostasis, whereas TNF-α and IL-1β predominate in 
inflammatory pathology arising from a breakdown in 
mucosal tolerance (reviewed in Foey, 2012).  The balance 
between such pro-inflammatory and regulatory cytokines 
plays a vital role in the induction of expression and secretion 
of hBD-2, which acts as both an AMP and a modulator 
of immune responses.  TNF-α-stimulation induced both 
expression and secretion of TNF-α and IL-10 by colonic 
epithelial cells.  These cytokines were regulated by HK 
bacteria in a strain-dependent manner, where LF augmented 
both TNF-α mRNA expression and protein secretion, and 
LcS failed to significantly modulate TNF-α. Of particular 
interest, however, was the observation that TNF-α-induced 
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TNF-α mRNA and secreted protein levels correlated with 
each other, although induction of TNF-α mRNA appeared 
to be disproportionately large compared to the small levels 
of protein secreted. With respect to induction of IL-10, 
LcS failed to modulate both TNF-α-induced IL-10 mRNA 
expression and protein secretion. This lack of effect on 
protein secretion, despite a relatively high TNF-α-induction 
of IL-10 mRNA, may reflect the fact that IL-10 can also be 
produced as a membrane-bound activity (Fleming et al., 
1996), which may or may not be cleaved for secretion. On 
the other hand, HK LF suppressed TNF-α-induced IL-10 
mRNA and secreted protein levels. HK probiotic bacteria 
also differentially modulated IL-1β-induction of epithelial 
cell cytokines. LcS greatly augmented IL-1β-induced 
TNF-α mRNA, which failed to be reflected by secreted 
protein. LF only partially upregulated TNF-α mRNA but 
had no effect on secreted protein.  This again could have 
been reflected by mRNA stability and posttranscriptional 
processes resulting in membrane-bound, endogenous 
protein rather than secreted protein. In addition, this 
may also be indicative of TNF-α scavenging systems via 
TNF-Rp75, perpetuating an inflammatory response whilst 
concurrently reducing secreted TNF-α protein levels or 
shed TNF-R binding to and interfering with the TNF-α 
ELISA detection system. A different pattern of modulation 
was displayed for IL-10, where probiotic strain-specific 
responses were observed; LcS suppressed IL-1β-induced 
IL-10 and LF augmented IL-10. Taken together, it would 
appear that LcS modulation exhibits a pro-inflammatory 
profile and LF an anti-inflammatory profile when being 
induced by IL-1β, whereas TNF-α-stimulation of Caco-2 
cells resulted in LF exhibiting a pro-inflammatory profile 
and LcS a balanced pro- and anti-inflammatory profile. 
This effect on modulatory behaviour is also demonstrated 
in macrophages, where differential regulation of pro-
inflammatory cytokines is dependent on both probiotic 
bacterial strain and differentiation status of the responding 
cell (Habil et al., 2011, 2012).
IBD is a chronic inflammatory pathology that exhibits a wide 
range of inflammatory mechanisms. These mechanisms 
involve a variety of cells and molecules, which depend 
on trigger, genetics and immune-inflammatory stimuli. 
There is a cytokine expression hierarchy in which TNF-α 
and IL-1β predominate this pathology. These cytokines 
represented an appropriate focus for investigation, as they 
are generally co-expressed in inflammatory pathologies. 
The study of single cytokine effects is valid as most 
inflammatory pathologies exhibit differential cytokine 
dominance, however, the present investigation represents 
a starting point from which to interpret complex multi-
cytokine responses. Future studies will focus on probiotic 
modulation of expression and functionality of more 
appropriate cytokine combinations, including TNF-α and 
IL-1β with other pro-inflammatory cytokines expressed in 
IBD, such as IL-12, IL-6, IL-15, IL-18, and IL-17, reflective 
of the 3-dimensional nature of the disease characterised by 
multifactoral and multicellular interactions.
This study demonstrated that the induction and modulation 
of both hBD-2 and cytokines TNF-α and IL-10 were 
probiotic bacterial strain- and inflammatory stimulus-
dependent. The role of such cytokines in inducing/
regulating epithelial cell hBD-2 became an important focus. 
Prior to inflammatory stimulation, Caco-2 cells expressed 
an endogenous IL-10 activity negatively regulating hBD-2, 
as evidenced by the augmentation of hBD-2 mRNA and 
secreted protein by anti-IL-10 neutralising antibody in the 
absence of stimulation. This observation alone conforms 
to the homeostatic, regulatory nature of healthy tolerant, 
un-stimulated intestinal epithelial cells. This negative 
regulatory aspect of endogenous IL-10 was reproduced 
when hBD-2 was stimulated by TNF-α. Surprising, however, 
was the observation that in the case of IL-1β-induced hBD-2 
endogenous IL-10 exhibited a positive regulatory nature, 
as neutralisation suppressed hBD-2. In the context of IBD, 
where CD and UC exhibit differential modulation of hBD-
2 (Aldhous, 2009; Wehkamp, 2005), hence anti-microbial 
activity, this variation in hBD-2 in response to endogenous 
IL-10 may be reflective of which pro-inflammatory cytokine 
predominates specific IBD pathologies.
To confirm the regulatory effect of endogenous IL-10, this 
anti-inflammatory cytokine was added exogenously to 
IL-1β- and TNF-α-stimulated epithelial cells in the presence 
or absence of LF and LcS. Exogenous IL-10 suppressed 
TNF-α-induced hBD-2 mRNA and secreted protein to 
basal levels. hBD-2 mRNA and secreted protein were only 
partially suppressed by IL-10 in the case of IL-1β-activated 
epithelial cells. This contrasts with the endogenous IL-10 
result, where neutralisation suppressed hBD-2. It is possible 
that this unexpected sensitivity between exogenous and 
endogenous IL-10 reflects that endogenous, membrane-
associated IL-10 requires direct cell-to-cell contact.  The 
fact this observation is in contrast to the TNF-α-induced 
response may reflect differential IL-10 induction responses 
and IL-10R subunit patterns between IL-1β- and TNFα-
stimulated Caco-2 cells. This suggests that IL-1β and TNF-α 
induce a differential sensitivity to IL-10 activity, possibly 
through differential IL-10R expression or utilisation of 
IL-10-dependent signalling components, such as JAK2 and 
STAT-3 (see review by Moore et al., 2001). This observation 
alone may explain the rather poor anti-inflammatory 
effects of IL-10 when used to treat IBD (Tilg et al., 2002); 
prognosis being dependent on prevalence of inflammatory 
cytokine. Regarding the effect of HK probiotic strains, 
both LcS and LF partially rescued the IL-10-induced 
suppression of hBD-2 (mRNA and secreted protein) 
observed in TNF-α-stimulated epithelial cells. In the case 
of IL-1β-induced hBD-2, LcS and LF totally rescued IL-10-
mediated suppression of mRNA. In contrast, LF further 
suppressed IL-10-mediated suppression of hBD-2 secreted 
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protein. This LF-dependent response may be indicative of 
the need for careful investigation and future therapeutic 
intervention, where LF use, in combination with IL-10, 
maybe detrimental to IBD resulting in the decreased hBD-2 
secretion associated with IBD pathology.
This study demonstrated that hBD-2 was differentially 
regulated by IL-10 and the HK probiotic strains LcS and 
LF in a manner dependent on inflammatory stimulus 
encountered by the intestinal epithelial cell. It is however, 
difficult to rationalise these results in the context of 
inflammatory pathology, such as IBD. hBD-2 was 
reported to be reduced in CD (Wehkamp, 2005), hence 
potentially resulting in overgrowth of pathogenic hBD-
2-sensitive bacteria and perpetuation of inflammatory 
pathology. It is counterintuitive that the anti-inflammatory 
cytokine IL-10 suppresses hBD-2 and probiotic bacteria 
positively regulating IL-10 display a rescue effect. In 
addition, defensins have been shown to modulate cytokine 
production and DC functionality (Biragyn et al., 2002; 
Presicce et al., 2009). It is possible that reduced hBD-2 
expression observed in CD not only results in a weakened 
anti-pathogen response, but also a weakened protective 
immune response mediated by DCs and other innate 
immune cells. Indeed, the complexity of hBD-2 function 
is being unravelled as hBD-2, and defensins in general, have 
been shown to be immune-modulatory, whereby regulating 
cytokine production, such as IL-1β, and inducing adhesion/
migration of inflammatory Th17 subsets to endothelial 
cells (Ghannam et al., 2011; Shi et al., 2007). Exactly what 
modulatory function hBD-2 may feedback to epithelial cells 
and underlying mucosal immune cells awaits investigation.
Immune responses are generally weakened or dysfunctional 
in chronic inflammatory environments. This is induced by 
chronic inflammatory responses mediated by cytokines, 
such as TNF-α, resulting in suppressed receptor 
expression or dysfunctional receptor transduction events 
(reviewed by Cope, 1998). Long-term exposure to the 
inflammatory cytokines IL-1β or TNF-α, and pathogenic 
microbes/PAMPs may dysregulate immune inflammatory 
responses resulting in reduced protection to microbes and 
uncontrolled perpetuation of inflammation. The role of HK 
probiotic bacterial strains is quite different with respect 
to hBD-2 modulation in the context of IL-1β or TNF-α 
inflammatory stimuli, displaying both positive and negative 
responses. It is probable that host epithelial responses to 
beneficial microbes will differ according to probiotic strain, 
inflammatory stimuli and duration of stimuli (acute vs. 
chronic). With respect to chronic inflammatory stimuli, 
such as is the case in IBD, probiotics may exert different 
responses to those observed in acute situations, possibly 
inducing or perpetuating destructive, harmful inflammatory 
mechanisms. Future research efforts will help clarify these 
issues of probiotic effects in acute or chronic inflammatory 
pathology. Until then, a cautionary approach to probiotic 
usage by IBD patients is recommended.
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